CFD
EFTR

Creative Financial Designs’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Creative Financial Designs’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-17
Closed -$6K – 1476
2021
Q3 		$6K Buy
+17
New +$5.48K ﹤0.01% 1139

Other funds holding EFTR

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Financial Designs's EFTR Position: Q4 2021 in Review

Creative Financial Designs sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q4 2021, closing a stake of 17 shares — an estimated $6K sold.

Creative Financial Designs first reported a position in EFTR in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 18 funds tracked by Wall St. Rank hold EFTR as of Q4 2021.

  • Creative Financial Designs reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Creative Financial Designs sold 17 eFFECTOR Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $6K.
  • Creative Financial Designs first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Creative Financial Designs's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $6K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Creative Financial Designs's 13F filing for Q4 2021, filed 26 Jan 2022.